The fund is permitted to invest directly and indirectly in equities of companies tied economically to any country in the world, including emerging countries. GMO Quality is traded on NASDAQ Exchange in the United States. With a beta of 0.86, GMO Quality shows lower sensitivity to broader market movements; It is managed by GMO in the Large Blend category.
GMO Quality shares are quoted at $36.03, delivering a 0.44% decrease on the day after opening at $36.19. Based on structural risk metrics, GMO Quality reflects a 22% probability of significant NAV decline over the next few years. Over the last 90 trading days, GMO Quality has produced modest risk-adjusted performance, consistent with mild return metrics. The performance scores reflect data spanning February 6, 2026 through May 7, 2026. Learn more.
Gmo Quality Fund [GQLIX] is traded in USA. The fund is listed under the Large Blend category and is part of the GMO family. This fund currently has accumulated $5.84 billion in assets under management (AUM) with no minimum investment requirements. Gmo Quality Fund is currently producing a year-to-date (YTD) return of 1.89%, while the total return for the last 3 years is 18.85%. GMO Quality is an operator in the large blend segment where revenue is driven by core operating activity and end-market demand. GMO Quality financial stability analysis
For GMO Quality, daily indicators reveal whether a price move in the fund's holdings is gaining conviction or fading. For Large Blend funds, accumulation and distribution signals track whether capital is flowing into or out of GMO Quality's underlying positions. Indicator values are snapshots from the most recent session. They work best as inputs to a repeatable review process. For GMO Quality, the practical value is catching momentum shifts in the underlying holdings early enough to adjust allocation.
A forecast framework for GMO Quality starts with observed NAV patterns. Trends and reversals in the fund often precede fundamental news. Over three years, Quality returned 18.8%. The practical edge is understanding when the confidence interval around the fund's NAV forecast is narrow versus wide. Forecast uncertainty tends to increase around fiscal year-end, major economic releases, and fund rebalancing dates. The most informative fund forecast narrows the range of plausible NAV outcomes enough to support a sizing or rebalancing decision.
Liquidity and pricing cadence can influence observed volatility and execution context. Lower trading activity may introduce occasional variability in execution conditions. The five-year return stands at 12.0%.
Methodology
Unless otherwise specified, data for Gmo Quality Fund is derived from fund disclosures (prospectus language, holdings reports, and periodic statements where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on instrument type. Gmo Quality Fund market data and reported NAV may reflect delayed updates. Data may be delayed depending on reporting sources and market conventions. All analytics presented are generated using Macroaxis quantitative models that incorporate financial statement analysis, market data, and risk metrics to ensure consistency and comparability. Assumptions: This report is built using public fund disclosures, holdings reports, and market data feeds and official sources including U.S. Securities and Exchange Commission (SEC) via EDGAR. Normalization for analytical consistency may introduce small timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Research Sources
Gmo Quality Fund may have reference inputs that incorporate holdings disclosures, category classification, and NAV-derived statistics where available. Updates may occur throughout the day.
Editorial review and methodology oversight provided by: Michael Smolkin, Member of Macroaxis Board of Directors